Use of transgenic animals to improve human health and animal production
- PMID: 16008757
- PMCID: PMC7190005
- DOI: 10.1111/j.1439-0531.2005.00596.x
Use of transgenic animals to improve human health and animal production
Abstract
Contents Transgenic animals are more widely used for various purposes. Applications of animal transgenesis may be divided into three major categories: (i) to obtain information on gene function and regulation as well as on human diseases, (ii) to obtain high value products (recombinant pharmaceutical proteins and xeno-organs for humans) to be used for human therapy, and (iii) to improve animal products for human consumption. All these applications are directly or not related to human health. Animal transgenesis started in 1980. Important improvement of the methods has been made and are still being achieved to reduce cost as well as killing of animals and to improve the relevance of the models. This includes gene transfer and design of reliable vectors for transgene expression. This review describes the state of the art of animal transgenesis from a technical point of view. It also reports some of the applications in the medical field based on the use of transgenic animal models. The advance in the generation of pigs to be used as the source of organs for patients and in the preparation of pharmaceutical proteins from milk and other possible biological fluids from transgenic animals is described. The projects in course aiming at improving animal production by transgenesis are also depicted. Some the specific biosafety and bioethical problems raised by the different applications of transgenesis, including consumption of transgenic animal products are discussed.
References
-
- Abbott A, 2004: Geneticists prepare for deluge of mutant mice. Nature 432, 541. - PubMed
-
- Acharya T, Daar AS, Singer PA, 2003: Biotechnology and the UN's Millennium Development Goals. Nat Biotechnol 21, 1434–1436. - PubMed
-
- Auerbach AB, Norinsky R, Ho W, Losos K, Guo Q, Chatterjee S, Joyner AL, 2003: Strain‐dependent differences in the efficiency of transgenic mouse production. Transgenic Res 12, 59–69. - PubMed
-
- Baer A, Bode J, 2001: Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. Curr Opin Biotechnol 12, 473–480. - PubMed
-
- Bawden CS, Dunn SM, McLaughlan J, Nesci A, Powell BC, Walker SK, Rogers GE, 1999: Transgenesis with ovine keratin: expression in the sheep wool follicle for fibres with new properties. Transgenic Res 8, 459–461.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
